Related Experiment Videos
Taurodeoxycholic acid stimulates rabbit gallbladder eicosanoid release
S I Myers1, A Riva, B Kalley-Taylor
1Department of Surgery, University of Texas Southwestern Medical Center, Dallas.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|January 1, 1995
Summary
Taurodeoxycholic acid stimulates gallbladder eicosanoid release, particularly PGI2 and PGE2. This suggests a link between elevated taurodeoxycholic acid in bile and gallbladder inflammation in cholecystitis models.
Area of Science:
- Gastroenterology
- Biochemistry
- Inflammation Research
Background:
- Common bile duct ligation in rabbits increases gallbladder taurodeoxycholic acid and eicosanoid release.
- Taurodeoxycholic acid is a known mediator of gallbladder inflammation.
Purpose of the Study:
- To test if taurodeoxycholic acid stimulates endogenous gallbladder eicosanoid release.
- To investigate the role of taurodeoxycholic acid in gallbladder inflammation.
Main Methods:
- Rabbit gallbladders were perfused in vitro with varying doses of taurodeoxycholic acid.
- Effluent was analyzed for eicosanoids (6-keto-PGF1 alpha, PGE2, TXB2) using enzyme immunoassay.
- The effect of indomethacin on eicosanoid release was assessed to confirm de novo synthesis.
Main Results:
- Taurodeoxycholic acid increased gallbladder eicosanoid release in a dose-dependent manner.
- 6-keto-PGF1 alpha and PGE2 release were significantly higher than thromboxane B2.
- Indomethacin reduced eicosanoid release, indicating de novo synthesis.
Conclusions:
- Increased gallbladder PGI2 and PGE2 in cholecystitis models may be linked to elevated taurodeoxycholic acid levels.
- Taurodeoxycholic acid plays a role in stimulating gallbladder eicosanoid synthesis and release.
- This study elucidates a mechanism contributing to gallbladder inflammation.